A Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in Chinese People

NCT05549206 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

350

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS-CoV-2

Interventions

BIOLOGICAL: SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine low dose
BIOLOGICAL: SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine high dose
DRUG: Placebo

Sponsor

AIM Vaccine Co., Ltd.

Collaborators

[object Object]
[object Object]